These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35702572)

  • 1. Mind the Covid-19 crisis: An evidence-based implementation of
    Crescenzi R; Giua M; Sonzogno GV
    J Policy Model; 2021; 43(2):278-297. PubMed ID: 35702572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prospects for the European Union's Budgetary Policy].
    Überblick
    Wirtschaftsdienst; 2021; 101(2):77. PubMed ID: 33642643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EU After COVID-19: An Opportunity for Policy Coordination.
    Díaz A; Puch LA
    Inter Econ; 2021; 56(4):197-200. PubMed ID: 34376866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European Union implementation of Article 5.3 of the Framework Convention on Tobacco Control.
    Hawkins B; Holden C
    Global Health; 2018 Aug; 14(1):79. PubMed ID: 30071862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Call for More Effective Regulation of Clinical Trials with Advanced Therapy Medicinal Products Consisting of or Containing Genetically Modified Organisms in the European Union.
    Beattie S;
    Hum Gene Ther; 2021 Oct; 32(19-20):997-1003. PubMed ID: 33843251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. European activities in radiation protection in medicine.
    Simeonov G
    Radiat Prot Dosimetry; 2015 Jul; 165(1-4):34-8. PubMed ID: 25870434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Italian National Recovery and Resilience Plan: a Healthcare Renaissance after the COVID-19 crisis?
    Filippini T; Vinceti SR
    Acta Biomed; 2021 Nov; 92(S6):e2021463. PubMed ID: 34787594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Public funding for research on antibacterial resistance in the JPIAMR countries, the European Commission, and related European Union agencies: a systematic observational analysis.
    Kelly R; Zoubiane G; Walsh D; Ward R; Goossens H
    Lancet Infect Dis; 2016 Apr; 16(4):431-40. PubMed ID: 26708524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European Union and Public Health Emergencies: Expert Opinions on the Management of the First Wave of the COVID-19 Pandemic and Suggestions for Future Emergencies.
    Gontariuk M; Krafft T; Rehbock C; Townend D; Van der Auwermeulen L; Pilot E
    Front Public Health; 2021; 9():698995. PubMed ID: 34490183
    [No Abstract]   [Full Text] [Related]  

  • 11. Organ transplantation and the European Union, 2009-2015 developments.
    Van der Spiegel S; Schröder-Bäck P; Brand H
    Transpl Int; 2020 Jun; 33(6):603-611. PubMed ID: 32097506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electronic Communication with Public Administration in the Time of COVID-19-Poland's Experience.
    Klich A
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33466944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on the Spatial Differentiation of Public Health Service Capabilities of European Union under the Background of the COVID-19 Crisis.
    Ding X; Cai Z; Zhu W; Fu Z
    Healthcare (Basel); 2020 Sep; 8(4):. PubMed ID: 32987625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transposition and implementation of EU rare disease policy in Eastern Europe.
    Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will the EU Clinical Trials Regulation Support the Innovative Industry in Bringing New Medicines Faster to Patients?
    Atzor S; Gokhale S; Doherty M
    Pharmaceut Med; 2013 Apr; 27(2):75-82. PubMed ID: 23585715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EUROPLAN: a project to support the development of national plans on rare diseases in Europe.
    Taruscio D; Gentile AE; De Santis M; Ferrelli RM; Posada de la Paz M; Hens M; Huizer J; Fregonese L; Stefanov R; Bottarelli V; Weinman A; Le Cam Y; Gavhed D; Mincarone P; Bushby K; Frazzica RG; Donati C; Vittozzi L; Jessop E
    Public Health Genomics; 2013; 16(6):278-87. PubMed ID: 24503588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harmonised human biomonitoring in Europe: activities towards an EU HBM framework.
    Joas R; Casteleyn L; Biot P; Kolossa-Gehring M; Castano A; Angerer J; Schoeters G; Sepai O; Knudsen LE; Joas A; Horvat M; Bloemen L
    Int J Hyg Environ Health; 2012 Feb; 215(2):172-5. PubMed ID: 21940209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Diseases and Social Costs Considerations on Undertaken Health Policy Interventions.
    Holecki T; Węgrzyn M; Frączkiewicz-Wronka A; Sobczyk K
    Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32326080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging mental health strategy of the European Union: a multi-level work-in-progress.
    Kelly BD
    Health Policy; 2008 Jan; 85(1):60-70. PubMed ID: 17643547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients as EU citizens? The implementation and corporatist stakeholders' perceptions of the EU cross-border health care directive in Austria.
    Diesenreiter C; Österle A
    Health Policy; 2021 Nov; 125(11):1498-1505. PubMed ID: 34526232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.